
Aradhana Sasan
Examiner (ID: 9005, Phone: (571)272-9022 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 1310 |
| Issued Applications | 752 |
| Pending Applications | 117 |
| Abandoned Applications | 467 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5271081
[patent_doc_number] => 20090074857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'Glycerophospholipids for the improvement of cognitive functions'
[patent_app_type] => utility
[patent_app_number] => 12/215080
[patent_app_country] => US
[patent_app_date] => 2008-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 23715
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20090074857.pdf
[firstpage_image] =>[orig_patent_app_number] => 12215080
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/215080 | Glycerophospholipids for the improvement of cognitive functions | Jun 23, 2008 | Issued |
Array
(
[id] => 5397403
[patent_doc_number] => 20090317466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'Fixed dose pharmaceutical composition comprising hyroxyurea and didanosine'
[patent_app_type] => utility
[patent_app_number] => 12/214372
[patent_app_country] => US
[patent_app_date] => 2008-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6413
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20090317466.pdf
[firstpage_image] =>[orig_patent_app_number] => 12214372
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/214372 | Fixed dose pharmaceutical composition comprising hyroxyurea and didanosine | Jun 17, 2008 | Abandoned |
Array
(
[id] => 4758961
[patent_doc_number] => 20080311187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'CRUSH RESISTAN DELAYED-RELEASE DOSAGE FORM'
[patent_app_type] => utility
[patent_app_number] => 12/140568
[patent_app_country] => US
[patent_app_date] => 2008-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 21799
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20080311187.pdf
[firstpage_image] =>[orig_patent_app_number] => 12140568
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/140568 | CRUSH RESISTAN DELAYED-RELEASE DOSAGE FORM | Jun 16, 2008 | Abandoned |
Array
(
[id] => 4758823
[patent_doc_number] => 20080311049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'ABUSE-PROOF DOSAGE FORM'
[patent_app_type] => utility
[patent_app_number] => 12/140665
[patent_app_country] => US
[patent_app_date] => 2008-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17496
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20080311049.pdf
[firstpage_image] =>[orig_patent_app_number] => 12140665
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/140665 | Abuse-proof dosage form | Jun 16, 2008 | Issued |
Array
(
[id] => 8532912
[patent_doc_number] => 08309065
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-13
[patent_title] => 'Hydrocarbon mixture and use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/665425
[patent_app_country] => US
[patent_app_date] => 2008-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16825
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12665425
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/665425 | Hydrocarbon mixture and use thereof | Jun 11, 2008 | Issued |
Array
(
[id] => 4793115
[patent_doc_number] => 20080294089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-27
[patent_title] => 'Dendritic Polymers for Use in Acoustically Mediated Intracellular Drug Delivery in vivo'
[patent_app_type] => utility
[patent_app_number] => 12/131097
[patent_app_country] => US
[patent_app_date] => 2008-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 51202
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0294/20080294089.pdf
[firstpage_image] =>[orig_patent_app_number] => 12131097
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/131097 | Dendritic Polymers for Use in Acoustically Mediated Intracellular Drug Delivery in vivo | May 31, 2008 | Abandoned |
Array
(
[id] => 4710660
[patent_doc_number] => 20080299186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-04
[patent_title] => 'COATINGS FOR APPLYING SUBSTANCES ONTO SUBSTRATE CARRIER'
[patent_app_type] => utility
[patent_app_number] => 12/130225
[patent_app_country] => US
[patent_app_date] => 2008-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7948
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20080299186.pdf
[firstpage_image] =>[orig_patent_app_number] => 12130225
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/130225 | COATINGS FOR APPLYING SUBSTANCES ONTO SUBSTRATE CARRIER | May 29, 2008 | Abandoned |
Array
(
[id] => 8538049
[patent_doc_number] => 08313770
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-20
[patent_title] => 'Modifying drug release in suspensions of ionic resin systems'
[patent_app_type] => utility
[patent_app_number] => 12/130762
[patent_app_country] => US
[patent_app_date] => 2008-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 10773
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12130762
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/130762 | Modifying drug release in suspensions of ionic resin systems | May 29, 2008 | Issued |
Array
(
[id] => 5929334
[patent_doc_number] => 20110039293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'Effervescent Solid Pharmaceutical Composition Comprising Dextrose and Process for its Preparation'
[patent_app_type] => utility
[patent_app_number] => 12/600225
[patent_app_country] => US
[patent_app_date] => 2008-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3651
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20110039293.pdf
[firstpage_image] =>[orig_patent_app_number] => 12600225
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/600225 | Effervescent Solid Pharmaceutical Composition Comprising Dextrose and Process for its Preparation | May 18, 2008 | Abandoned |
Array
(
[id] => 4698990
[patent_doc_number] => 20080221174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-11
[patent_title] => 'CONTROLLED RELEASE NISOLDIPINE COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/122450
[patent_app_country] => US
[patent_app_date] => 2008-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15352
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20080221174.pdf
[firstpage_image] =>[orig_patent_app_number] => 12122450
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/122450 | CONTROLLED RELEASE NISOLDIPINE COMPOSITIONS | May 15, 2008 | Abandoned |
Array
(
[id] => 6201987
[patent_doc_number] => 20110064773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-17
[patent_title] => ' PHARMACEUTICAL COMPOSITIONS COMPRISING A THYROID HORMON AND THEIR THERAPEUTIC USE'
[patent_app_type] => utility
[patent_app_number] => 12/600154
[patent_app_country] => US
[patent_app_date] => 2008-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 18967
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20110064773.pdf
[firstpage_image] =>[orig_patent_app_number] => 12600154
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/600154 | PHARMACEUTICAL COMPOSITIONS COMPRISING A THYROID HORMON AND THEIR THERAPEUTIC USE | May 15, 2008 | Abandoned |
Array
(
[id] => 6320980
[patent_doc_number] => 20100196475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'CONTROLLED RELEASE TABLET FORMULATION CONTAINING MAGNESIUM ALUMINOMETASILICATE'
[patent_app_type] => utility
[patent_app_number] => 12/451525
[patent_app_country] => US
[patent_app_date] => 2008-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 4821
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20100196475.pdf
[firstpage_image] =>[orig_patent_app_number] => 12451525
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/451525 | CONTROLLED RELEASE TABLET FORMULATION CONTAINING MAGNESIUM ALUMINOMETASILICATE | May 15, 2008 | Abandoned |
Array
(
[id] => 4739409
[patent_doc_number] => 20080233062
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'CATIONIC LATEX AS A CARRIER FOR ACTIVE INGREDIENTS AND METHODS FOR MAKING AND USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/116006
[patent_app_country] => US
[patent_app_date] => 2008-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 24110
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20080233062.pdf
[firstpage_image] =>[orig_patent_app_number] => 12116006
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/116006 | CATIONIC LATEX AS A CARRIER FOR ACTIVE INGREDIENTS AND METHODS FOR MAKING AND USING THE SAME | May 5, 2008 | Abandoned |
Array
(
[id] => 6353811
[patent_doc_number] => 20100086608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-08
[patent_title] => 'Methods and Devices for Detecting Binding Events via Zeta-Potential and Pharmacologically Active Compounds and Delivery Systems Identified Thereby'
[patent_app_type] => utility
[patent_app_number] => 12/593616
[patent_app_country] => US
[patent_app_date] => 2008-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2640
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20100086608.pdf
[firstpage_image] =>[orig_patent_app_number] => 12593616
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/593616 | Methods and devices for detecting binding events via zeta-potential and pharmacologically active compounds and delivery systems identified thereby | Apr 3, 2008 | Issued |
Array
(
[id] => 4718735
[patent_doc_number] => 20080241257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'Biodegradable Nanoparticles Incorporating Highly Hydrophilic Positively Charged Drugs'
[patent_app_type] => utility
[patent_app_number] => 12/059483
[patent_app_country] => US
[patent_app_date] => 2008-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5011
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20080241257.pdf
[firstpage_image] =>[orig_patent_app_number] => 12059483
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/059483 | Biodegradable Nanoparticles Incorporating Highly Hydrophilic Positively Charged Drugs | Mar 30, 2008 | Abandoned |
Array
(
[id] => 4959775
[patent_doc_number] => 20080274200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'DOSE TITRATABLE LIQUID DOSAGE FORMS OF ACID LABILE DRUGS'
[patent_app_type] => utility
[patent_app_number] => 12/048570
[patent_app_country] => US
[patent_app_date] => 2008-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4124
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20080274200.pdf
[firstpage_image] =>[orig_patent_app_number] => 12048570
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/048570 | DOSE TITRATABLE LIQUID DOSAGE FORMS OF ACID LABILE DRUGS | Mar 13, 2008 | Abandoned |
Array
(
[id] => 6441914
[patent_doc_number] => 20100104599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-29
[patent_title] => 'Compositions and Methods For Enhancing Immune System of Felines'
[patent_app_type] => utility
[patent_app_number] => 12/528153
[patent_app_country] => US
[patent_app_date] => 2008-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3842
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20100104599.pdf
[firstpage_image] =>[orig_patent_app_number] => 12528153
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/528153 | Compositions and Methods For Enhancing Immune System of Felines | Feb 21, 2008 | Abandoned |
Array
(
[id] => 111889
[patent_doc_number] => 07713548
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-11
[patent_title] => 'Amorphous solid dispersions'
[patent_app_type] => utility
[patent_app_number] => 12/029691
[patent_app_country] => US
[patent_app_date] => 2008-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4955
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/713/07713548.pdf
[firstpage_image] =>[orig_patent_app_number] => 12029691
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/029691 | Amorphous solid dispersions | Feb 11, 2008 | Issued |
Array
(
[id] => 4832969
[patent_doc_number] => 20080131516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-05
[patent_title] => 'Granule formation'
[patent_app_type] => utility
[patent_app_number] => 12/069124
[patent_app_country] => US
[patent_app_date] => 2008-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3168
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20080131516.pdf
[firstpage_image] =>[orig_patent_app_number] => 12069124
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/069124 | Granule formation | Feb 6, 2008 | Issued |
| 11/971460 | FENOFIBRIC ACID FORMULATIONS AND METHODS OF MAKING | Jan 8, 2008 | Abandoned |